TY - JOUR AU - Gordon, Erlinda AU - Dang, Jonathan AU - Angel, Nicole L. AU - Brigham, Don A. AU - Ostendorf, Lance AU - Jafari, Omid AU - Chawla, Sant P. AU - Hall, Frederick L. PY - 2021/03/03 Y2 - 2024/03/29 TI - Control of Metastatic Tumor Growth in a Patient with Sporadic Metastatic Malignant Peripheral Nerve Sheath Tumor (sMPNST) Using the Hope Protocol, an Alternative Treatment Regimen for Cancer JF - Integrative Journal of Medical Sciences JA - Integr J Med Sci VL - 8 IS - SE - CASE REPORTS DO - 10.15342/ijms.2021.453 UR - https://mbmj.org/index.php/ijms/article/view/453 SP - AB - <p>Metastatic sporadic malignant peripheral nerve sheath tumor (sMPNST) is associated with only 17% five-year survival rate using standard chemotherapy and there are no 10-year survival reports with the exception of a case report wherein a patient with metastatic sMPNST is still alive with no active disease and on no further cancer therapy, &gt;12 years from DeltaRex-G treatment initiation. In this case report, we describe an interim alternative treatment regimen designed and used by a patient with metastatic sMPNST, while awaiting the return, GMP bioproduction, and QC certification of DeltaRex-G as a potential treatment option. We report on the successful control of metastatic tumor growth over a one-year treatment period using the Hope Protocol consisting of artemisinin, curcumin, cannabis oil, disulfiram, fenbendazole, mebendazole, albendazole, atorvastatin, doxycycline, vitamin C, vitamin E, a plant-based diet, sans refined sugar, yoga, acupuncture, meditation, exercise and hot sauna, and we discuss their biochemical mechanisms of action.</p> ER -